Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reengaging in licensing discussions in light of escalating royalyty rate ....
Reply New Message
Back To Forum List View

Reengaging in licensing discussions in light of escalating royalyty rate ....

posted on Oct 05, 2009 11:40AM

You really have to like this language from the PR.

Despite the risk of willful infringement in cases where companies delay licensing decisions on the basis of reexams, companies have been awaiting the outcome of US'336 and are now reengaging in licensing discussions in light of the escalating royalty rate structure of the MMP Portfolio(TM) Licensing Program.

All the best,

Steve

2 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply